NCT07602946: SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial of BMS-986504 in Patients With MTAP-deficient Relapsed Mesothelioma
- State
- Not started
- Phase
- Phase 2
- People
- 30 planned
- Started
- 11 May 2026
- Primary completion
- Jul 2027
- Arms
- A phase II trial of BMS-986504 in patients with MTAP-deficient relapsed mesothelioma
- Results
- None posted
- 22 May 2026: Trial registered